GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...
Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ...
Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...
Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...
The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...
People buying the peptide retatrutide online could suffer from side-effects ranging from nausea to pancreatitis ...
We caught one 'advanced aesthetics practitioner' brazenly selling us retatrutide, an experimental drug seen as the 'King Kong ...
But 'capacity constraints' is expected to have a restraining impact on the economy, new report from AIB shows.
Novo Nordisk and Eli Lilly deny partnership with Mangoceuticals for weight-loss drugs, causing Mangoceuticals' shares to ...
Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...
ObesityWeek 2025, held in Atlanta from November 4-7, showcased unprecedented clinical data that signals a fundamental shift in the obesity treatment landscape. The most striking breakthrough at ...
Wegovy’s key competitor is Eli Lilly’s GLP-1 drug Mounjaro (tirzepatide), which became India’s top-selling medicine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback